A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial

KSO Corporation0 个研究点目标入组 80 人开始时间: 2019年1月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Individuals who use oral medication affecting lipid metabolism (2)Individuals who constantly use supplements and/or functional foods, including food for specified health use and/or food with function claims, affecting lipid metabolism (3)Individuals who are suffered from or under treatment of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder (4)Individuals who have a chronic disease and use medicines continuously (5)Individuals who are diagnosed as severe anemia and not suitable for frequent collection of blood (6)Individuals who had an onset diarrhea within one week from the date of screening, and who is prone to diarrhea always (7)Individuals who are diagnosed as familial hyperlipidemia (8)Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (9)Individuals who are judged as unsuitable for the study by the investigator for the other reasons

发起方